Aridis Pharmaceuticals, Inc. Annual Depreciation in USD from 2017 to 2021

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Aridis Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2017 to 2021.
  • Aridis Pharmaceuticals, Inc. Depreciation for the quarter ending September 30, 2022 was $123K, a 32.3% increase year-over-year.
  • Aridis Pharmaceuticals, Inc. Depreciation for the twelve months ending September 30, 2022 was $539K, a 51% increase year-over-year.
  • Aridis Pharmaceuticals, Inc. annual Depreciation for 2021 was $430K, a 29.5% increase from 2020.
  • Aridis Pharmaceuticals, Inc. annual Depreciation for 2020 was $332K, unchanged from 2019.
  • Aridis Pharmaceuticals, Inc. annual Depreciation for 2019 was $332K, a 19.4% increase from 2018.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $430K +$98K +29.5% Jan 1, 2021 Dec 31, 2021 10-K 2022-04-13
2020 $332K $0 0% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-13
2019 $332K +$54K +19.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-30
2018 $278K +$221K +388% Jan 1, 2018 Dec 31, 2018 10-K 2020-04-08
2017 $57K Jan 1, 2017 Dec 31, 2017 10-K 2019-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.